Sawai Group Holdings Co., Ltd. (4887) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sawai Group Holdings Co., Ltd. (4887:JPX), powered by AI.

Current Price
¥1,674
P/E Ratio
9.0
Market Cap
207.5B
Sector
Healthcare
What is the Sawai Group Holdings Co., Ltd. stock price forecast?

Sawai Group Holdings Co., Ltd. is currently trading at ¥1,674. View real-time AI analysis on Alpha Lenz.

What is Sawai Group Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Sawai Group Holdings Co., Ltd. on Alpha Lenz.

What is Sawai Group Holdings Co., Ltd.'s P/E ratio?

Sawai Group Holdings Co., Ltd.'s P/E ratio is 9.0.

Sawai Group Holdings Co., Ltd.

JPX · 4887
¥1,674-37(-2.16%)Market closedJPX regular session 09:00–15:00 JST
Ask about Sawai Group Holdings Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sawai Group Holdings Co., Ltd. trades at a P/E of 9.0 (undervalued) with solid ROE of 11.9%.

Ask for details

Company Overview

Sawai Group Holdings Co., Ltd. is an influential player in the pharmaceutical industry focusing on the manufacture and distribution of generic pharmaceuticals. The company's primary objective is to provide affordable and accessible medication options to the global market, emphasizing high quality and safety standards. Sawai Group Holdings engages in the development, production, and marketing of generic drugs that cater to a wide range of therapeutic areas, impacting both local and international healthcare sectors. Headquartered in Japan, the firm plays a significant role in the healthcare industry by addressing the ever-growing demand for cost-effective medication alternatives. Through continuous research and innovation, Sawai Group Holdings is committed to expanding its product portfolio and enhancing its contribution to global health care solutions.

CEOMr. Mitsuo Sawai
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees3,310

Company Statistics

FY 2025

Profile

¥207,546,683,238Market Cap
¥189,024,000,000Revenue
0.00Shares Out
3,310Employees

Margins

29.81%Gross
19.15%EBITDA
11.01%Operating
10.54%Pre-Tax
12.13%Net

Valuation

9.05P/E
1.19P/B
1.10EV/Sales
7.19EV/EBITDA
615.87P/FCF

Growth (CAGR)

-0.83%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

6.23%ROA
11.87%ROE
5.69%ROIC

Financial Health

¥38,785,000,000Cash & Cash Equivalents
¥141,984,000,000Net Debt
103.98%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sawai Group Holdings Co., Ltd. (ticker: 4887) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 3,310 employees. Market cap is $207.5B.

The current price is 1,674 with a P/E ratio of 9.05x and P/B of 1.19x.

ROE is 11.87% and operating margin is 11.01%. Annual revenue is $189.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sawai Group Holdings Co., Ltd. (4887) Stock Forecast 2026 ¥1,674 — Price, Financials & Analyst Targets | Alpha Lenz